Get access

Risedronate for the prevention and treatment of postmenopausal osteoporosis

  • Withdrawn
  • Review
  • Intervention


  • A Cranney,

  • JD Adachi,

  • G Guyatt,

  • A Papaioannou,

  • VA Robinson,

  • BJ Shea,

  • P Tugwell,

  • LM Waldegger,

  • B Weaver,

  • G Wells,

  • N Zytaruk

Dr Ann Cranney, Division of Rheumatology, Ottawa Hospital, 1053 Carling Ave, Ottawa, Ontario, K1Y 4E9, CANADA.

Reason for withdrawal from publication

Cochrane Funding Arbitration panel recommended withdrawal of this review.

Get access to the full text of this article